Favorable Effects of Inhaled Treprostinil in Severe Pulmonary Hypertension-Reference-Cited by-同舟云学术

Favorable Effects of Inhaled Treprostinil in Severe Pulmonary Hypertension

Published:2006-10 Issue:8 Volume:48 Page:1672-1681
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Voswinckel Robert,Enke Beate,Reichenberger Frank,Kohstall Markus,Kreckel Andree,Krick Stefanie,Gall Henning,Gessler Tobias,Schmehl Thomas,Ghofrani Hossein A.,Schermuly Ralph Theo,Grimminger Friedrich,Rubin Lewis J.,Seeger Werner,Olschewski Horst

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference14 articles.

1. Pulmonary arterial hypertension: a look to the future;Rubin;J Am Coll Cardiol,2004

2. Prostanoid therapy for pulmonary arterial hypertension;Badesch;J Am Coll Cardiol,2004

3. Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease;Oudiz;Chest,2004

4. Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension;Gomberg-Maitland;Am J Respir Crit Care Med,2005

5. Inhaled iloprost for severe pulmonary hypertension;Olschewski;N Engl J Med,2002

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Potential of Treprostinil Inhalation Powder for Patients with Pulmonary Arterial Hypertension: Evidence to Date;Drug, Healthcare and Patient Safety;2024-06

2. Pharmacological Update and Emerging Treatments of Pulmonary Hypertension;Cardiology in Review;2024-01-31

3. Prostaglandin and prostaglandin receptors: present and future promising therapeutic targets for pulmonary arterial hypertension;Respiratory Research;2023-11-01

4. Inhaled mosliciguat (BAY 1237592): targeting pulmonary vasculature via activating apo-sGC;Respiratory Research;2022-10-01

5. Hemodynamics of Treprostinil Inhalation Solution and Treprostinil Inhalation Powder;American Journal of Therapeutics;2022-06-21